SCHEMBL5530548

SCHEMBL5530548

Cc1cccc2c(OC3CCN(CC(C)(C)C)CC3)cc(F)nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 3/20 0.39
SCN8A Q9UQD0 3/20 0.39
POLB P06746 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
TLR9 Q9NR96 1/20 0.38
TLR8 Q9NR97 1/20 0.38
TLR7 Q9NYK1 1/20 0.38
ADRA1A P35348 1/20 0.36
KCNH2 Q12809 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
S1PR5 Q9H228 3/20 0.36
HRH1 P35367 1/20 0.35
CCR3 P51677 1/20 0.35
PARP1 P09874 1/20 0.35
PARP2 Q9UGN5 1/20 0.35
KDM4E B2RXH2 3/20 0.34
GAA P10253 2/20 0.34
MCHR1 Q99705 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532059 0.88 SCN1A (0.39) SCN1ASCN8APOLBL3MBTL1KCNH2
SCHEMBL8236599 0.88 POLB (0.38) SCN1ASCN8APOLBL3MBTL1TLR9
SCHEMBL5528228 0.86 KCNH2 (0.38) SCN1ASCN8AL3MBTL1ADRA1AKCNH2
SCHEMBL5530528 0.85 HRH3 (0.41) SCN1ASCN8ATLR9TLR8TLR7
SCHEMBL5530051 0.83 HRH1 (0.41) SCN1ASCN8AL3MBTL1TLR9TLR8
SCHEMBL5525555 0.81 HTR1A (0.39) POLBL3MBTL1ADRA1AKCNH2HRH1
SCHEMBL5529546 0.81 HRH3 (0.42) SCN1ASCN8ATLR9TLR8TLR7
SCHEMBL5531991 0.78 SCN8A (0.42) SCN1ASCN8AL3MBTL1ADRA1AKCNH2
SCHEMBL5526609 0.77 SCN8A (0.49) SCN1ASCN8A
SCHEMBL5532960 0.77 SCN8A (0.38) SCN1ASCN8AADRA1AKCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197509-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2007-08-23 US disclosed
US-20070197509-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2007-08-23 US disclosed
US-20070197509-A1 Compositions and methods for modulating gated ion channels PAINCEPTOR PHARMA CORPORATION (CA) 2007-08-23 US disclosed
WO-2007071055-A1 COMPOSITIONS AND METHODS FOR MODULATING GATED ION CHANNELS PAINCEPTOR PHARMA CORPORATION (CA) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197509-A1 Compositions and methods for modulating gated ion channels KCNN3, KCNN2, HCN3 SCN1A 89/4885SCN8A 103/4885POLB 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.